Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease

Research output: Contribution to journalJournal articleResearchpeer-review

  • Bytzer, Peter
  • Roger Jones
  • Nimish Vakil
  • Ola Junghard
  • Tore Lind
  • Börje Wernersson
  • John Dent
The efficacy of proton-pump inhibitor (PPI) therapy often is assessed to determine whether patients' symptoms are acid-related and if patients have gastroesophageal reflux disease (GERD), although the accuracy of this approach is questionable. We evaluated the diagnostic performance of the PPI test, in conjunction with other tests, for the diagnosis of GERD.
Original languageEnglish
JournalClinical Gastroenterology and Hepatology
Volume10
Issue number12
Pages (from-to)1360-6
Number of pages7
ISSN1542-3565
DOIs
Publication statusPublished - Dec 2012

    Research areas

  • Clinical Medicine, Esomeprazole Sodium, Esophageal pH Monitoring, Esophagoscopy, Gastroesophageal Reflux, Humans, Placebos, Primary Health Care, Proton Pump Inhibitors, Questionnaires, Sensitivity and Specificity, Single-Blind Method

ID: 47892215